Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of April 26 to 30, 2021. This […]
Here is what the editors at Physician’s Briefing chose as the most important COVID-19 developments for you and your practice for the week of April 26 to 30, 2021. This roundup includes the latest research news from journal studies and other trusted sources that is most likely to affect clinical practice.
Pandemic Tied to Mental Health Concerns in Pregnant, Postpartum Women
FRIDAY, April 30, 2021 (HealthDay News) — During the early days of the COVID-19 pandemic, elevated posttraumatic stress, anxiety/depression, and loneliness were highly prevalent in pregnant and postpartum women across 64 countries, according to a study published online April 21 in PLOS ONE.
COVID-19 Deaths Continue to Decline in the United States
FRIDAY, April 30, 2021 (HealthDay News) — In a sign that the COVID-19 pandemic is beginning to ebb in America, a new analysis reveals the seven-day average of new COVID-19 deaths in the United States has hit its lowest point since last October.
Brazil Second Country to Record More Than 400,000 COVID-19 Deaths
FRIDAY, April 30, 2021 (HealthDay News) — After 100,000 COVID-19 deaths in just one month, Brazil has become the second country in the world to record more than 400,000 deaths from the disease.
CDC: Cruise Ships Can Soon Resume Sailing in U.S. Waters
FRIDAY, April 30, 2021 (HealthDay News) — Cruise ships can resume sailing in U.S. waters as long as 98 percent of crew and 95 percent of customers are vaccinated against COVID-19, the U.S. Centers for Disease Control and Prevention says.
Side Effects of BNT162b2, ChAdOx1 nCoV-19 Vaccines Quantified
FRIDAY, April 30, 2021 (HealthDay News) — Systemic and local side effects to BNT162b2 and ChAdOx1 nCoV-19 vaccines occur at relatively low frequencies, according to a study published online April 27 in The Lancet Infectious Diseases.
Supply Steady for Existing Patients Receiving Opioids During COVID-19
FRIDAY, April 30, 2021 (HealthDay News) — Existing patients receiving opioid analgesics and buprenorphine for opioid use disorder have continued to receive medications during the COVID-19 pandemic, according to a study published online April 15 in JAMA Network Open.
Vaccination Linked to Drop in COVID-19 Hospitalization in ≥65s
THURSDAY, April 29, 2021 (HealthDay News) — Among adults aged 65 years and older, vaccination is associated with a reduced risk for COVID-19-associated hospitalization, according to research published in the April 28 early-release issue of the U.S. Centers for Disease Control and Prevention Morbidity and Mortality Weekly Report.
COVID-19 Pill Could Be Available Later This Year: Pfizer CEO
THURSDAY, April 29, 2021 (HealthDay News) — A pill to treat COVID-19 is being developed by Pfizer and could be available by the end of the year, company CEO Albert Bourla says.
Many Americans Have COVID-19 Vaccine Preferences
Trends Reported in Vaccination Coverage for Adolescents for 2025 
AAP Issues Recommendations for Pediatric RSV Vaccination in 2026-2027 Season 
2005 to 2023 Saw More U.S. Women Never Screened for Cervical Cancer 
4CMenB Vaccine Confers Modest Protection Against Gonorrhea in Teens 
Social Media Warnings Could Discourage Use Among Teens, Young Adults 
Digital Behavioral Health Game Reduces Depressive Symptoms in Teens .jpeg)
Flu Treatment With Oseltamivir Linked to Reduced Risk for Pediatric ICU Admissions, Length of Stay 
Reinitiating Obesity Meds After Bariatric Surgery Tied to Greater One-Year Weight Loss in Youths 
